Skip to main content

Table 5 Associations of confirmed or highly suspicious SARS-CoV-2 infection. Multivariable analysis

From: Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

  OR 95% CI p
 Disease duration ≥ 120 months 0.71 0.50 to 0.99 0.04
 Home lockdown 1.02 0.64 to 1.60 0.94
 PDN 1.23 1.04 to 1.44 0.02
 csDMARDs 0.89 0.55 to 1.43 0.62
 b/tsDMARDs 0.47 0.46 to 0.48 < 0.001
AUC 0.62    
  1. PDN prednisone, csDMARDs conventional synthetic disease-modifying anti-rheumatic drugs, b/ts DMARDs biological/targeted synthetic disease-modifying anti-rheumatic drugs. Highly suspicious infection: respiratory symptoms + contacts with COVID-19 cases